Page 50 - Process Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Geltor Adds Ingredient Science Industry Veterans to Leadership Team News provided by Share this article SAN LEANDRO, Calif., Feb. 2, 2021 /PRNewswire/ -- Biodesign company  Geltor, Inc. today announced the addition of three new senior executives to its leadership team to drive product innovation, operational excellence, and commercial growth for its specialty proteins. Joining the company are Scott Fabro as Vice President of Business Development, Alex Patist as Vice President of Operations, and Michele Champagne as Vice President of Commercial Development and Regulatory Affairs. "Our expande...

Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory - Synlogic to provide bioprocess and manufacturing in joint effort to engineer novel investigational medicines to address battle fatigue - News provided by Share this article Share this article CAMBRIDGE, Mass., Feb. 2, 2021 /PRNewswire/ -- A collaboration between MIT Voigt Lab and Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, has been recognized by the Air Force Research Laboratory (AFRL) as a Biotechn...

DiNAQOR Establishes New GMP Manufacturing Facility in Zurich News provided by Share this article Share this article PFÄFFIKON, Switzerland, Jan. 11, 2021 /PRNewswire/ -- DiNAQOR, a gene therapy platform company, today announced that it will establish its own GMP manufacturing capabilities with a new facility in the Bio-Technopark Schlieren-Zürich. This state-of-the-art 1200 sqm (13,000 sq. ft) GMP facility will produce adeno-associated virus (AAV)-based gene therapies and is co-located with DiNAQOR's Research & Development (R&D) facility. "Establishing DiNAQOR's own gene therapy manufa...

Introduction To ASTM E3263-20: By Andrew Walsh, Ralph Basile, Ovais Mohammad, Stéphane Cousin, Mariann Neverovitch, and Osamu Shirokizawa Part of the series Visual inspection has been widely used for many years by the pharmaceutical, biologics, and medical device industries after cleaning to release manufacturing equipment and devices. However, visual inspection has never been demonstrated to be an effective, reliable, or safe method to use for these inspections. Recently, the European Medicines Agency (EMA) issued a Q&A 1 to its guideline on determining health-based exposure limits (HBELs...

Fujifilm Diosynth Biotechnologies will establish a new process development and manufacturing facility for viral vectors and advanced therapies.